CMR Surgical today announced that Johnson & Johnson MedTech’s Ethicon business is collaborating with CMR to market the Versius surgical robotic system in select markets.
Commercial teams from two companies are working together on this collaboration. We plan to focus on sales to selected hospitals in Italy, France, Germany and Brazil.
Per Vegard Nerseth, CEO of CMR Surgical, said: news release“CMR continues to expand rapidly globally and we look forward to advancing this agreement in strategically important regions.”
The news comes as the Cambridge, UK-based surgical robotics start-up Over 100 Versius Robotic Surgical Systems Installed World wide. His Versius robots are now in operation in Europe, Asia, Australia, Latin America and the Middle East.
To meet growing demand, CMR Surgical is working to build a global manufacturing hub of approximately 75,000 square feet in Cambridgeshire.
This collaboration could boost CMR Surgical’s global expansion
Our partnership with Ethicon is the latest exciting development in the field of robotic-assisted surgery. Many companies large and small are trying to compete with the dominant soft tissue surgical robotics company, Intuitive. (Here are 16 robotic surgery companies you should know about. When There are eight more, including CMR.)
The Versius system is characterized by flexibility in port placement. This feature allows the procedure to be tailored to each patient’s needs. For example, surgeons can perform the procedure in the same way as laparoscopic surgery, but with the advantages of robotic surgery, according to the company. In addition, Versius has a small, lightweight and modular design that makes it “easy” to move around for healthcare provider staff.
According to CMR Surgical, Versius is the only small modular portable robot on the market. This design makes it suitable for hospitals and surgical care centers of all sizes. Surgeons have the flexibility to perform fully robotic surgery or a combination of robotic and manual laparoscopic surgery. As a result, the surgeon can decide what is best.
The partnership with Ethicon is in line with CMR Surgical’s strategy of rapid global expansion. At the same time, CMR Surgical said it would continue to work and collaborate independently. In addition, we continue to invest heavily in the training and services we provide to our customers.
Where is Johnson & Johnson Ethicon Heading in Surgical Robotics?
Statement shared with mass device J&J spokesperson Ryan Carbain elaborated on Ethicon’s goals for the partnership. This commercial partnership underscores his Ethicon commitment to providing healthcare his partners with best-in-class surgical solutions focused on the unique needs of every patient. ”
Meanwhile, there hasn’t been much news about J&J Ethicon’s plans for the Ottava system, the company’s soft tissue robotics play.
A company statement was shared today mass device “We remain excited and committed to the Ottava program and look forward to providing competitive soft tissue robotic solutions.”
Fortis Advisor there is an ongoing lawsuit On behalf of the Auris shareholders behind the Ottava technology and the previous Monarch robotic system, J&J acknowledged certain indications. Despite the challenges, Monarch continues to move forward, Earn a new 510(k) in May.
J&J acquired Auris for $3.4 billion in 2019. J&J describes the lawsuit as “absolutely without merit.”